Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.55 USD | -1.92% | +0.39% | +4.94% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 97.74M |
---|---|---|---|---|---|
Net income 2024 * | -110M | Net income 2025 * | -134M | EV / Sales 2024 * | - |
Net cash position 2024 * | 254M | Net cash position 2025 * | 172M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.03
x | P/E ratio 2025 * |
-1.12
x | Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.25% |
Latest transcript on Athira Pharma, Inc.
1 day | -1.92% | ||
1 week | +0.39% | ||
Current month | -2.67% | ||
1 month | +10.39% | ||
3 months | -2.67% | ||
6 months | +13.33% | ||
Current year | +4.94% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Litton
CEO | Chief Executive Officer | 56 | 19-07-10 |
Andrew Gengos
DFI | Director of Finance/CFO | 59 | 23-05-17 |
Rachel Lenington
COO | Chief Operating Officer | 51 | 21-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Grant Pickering
BRD | Director/Board Member | 56 | 22-01-26 |
John Fluke
BRD | Director/Board Member | 81 | 12-12-31 |
Joseph Edelman
BRD | Director/Board Member | 67 | 20-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +10.39% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-13 | 2.55 | -1.92% | 94,138 |
24-06-12 | 2.6 | +1.96% | 135,513 |
24-06-11 | 2.55 | 0.00% | 70,213 |
24-06-10 | 2.55 | 0.00% | 171,136 |
24-06-07 | 2.55 | +0.39% | 198,177 |
Delayed Quote Nasdaq, June 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.94% | 97.74M | |
+46.03% | 55.66B | |
-7.53% | 38.98B | |
+36.13% | 38.8B | |
-9.38% | 27.32B | |
+12.31% | 26.29B | |
-16.38% | 20.25B | |
+30.79% | 12.76B | |
+28.57% | 12.18B | |
-0.36% | 12.12B |
- Stock Market
- Equities
- ATHA Stock